TSX:BN • CA11271J1075
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BROOKFIELD CORP (BN.CA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-12-14 | RBC Royalbank | Downgrade | Outperform |
| 2022-12-13 | Scotiabank Capital | Downgrade | Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 95.924B 3.40% | 86.006B -10.34% | 75.1B -12.68% | 9.592B -87.23% | 11.116B 15.89% | N/A | |
| EBITDA YoY % growth | 30.022B 28.23% | 28.978B -3.48% | N/A -5.44% | 13.119B -52.12% | 14.308B 9.06% | N/A | |
| EBIT YoY % growth | 20.947B 33.17% | 19.241B -8.14% | 20.435B 6.21% | 6.393B -68.72% | 7.454B 16.60% | 9.02B 21.01% | |
| Operating Margin | 21.84% | 22.37% | 27.21% | 66.65% | 67.06% | N/A | |
| EPS YoY % growth | 2.02 -6.01% | 2.65 31.02% | 2.18 -17.63% | 3.00 37.42% | 3.71 23.72% | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.68 4.50% | 0.71 20.81% | 0.77 21.89% | 0.75 141.88% | 0.81 19.18% | 0.84 17.88% | 0.85 11.33% | 0.89 18.28% |
| Revenue Q2Q % growth | 1.692B -90.57% | 1.804B -90.02% | 2B -89.43% | N/A | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 1.732B -65.80% | 1.835B -56.08% | 2B -62.23% | N/A | N/A | N/A | N/A | N/A |
All data in USD
19 analysts have analysed BN.CA and the average price target is 76.16 CAD. This implies a price increase of 31.15% is expected in the next year compared to the current price of 58.07.
BROOKFIELD CORP (BN.CA) will report earnings on 2026-05-06.
The consensus EPS estimate for the next earnings of BROOKFIELD CORP (BN.CA) is 0.68 CAD and the consensus revenue estimate is 1.69B CAD.
The number of analysts covering BROOKFIELD CORP (BN.CA) is 19.